Following a surge in liquid biopsy technical advancements, and two exciting FDA approvals in August, the 5th Annual Liquid Biopsy for Precision .. Read more Oncology Summit is back and taking to the digital stage to keep you updated with the recent innovations in this fast growing field. With the need to demonstrate the clinical utility of testing at an all-time high, we will unite with pharma, biotechs and research institutes to address analytical, sensitivity, selectivity and market access barriers to accelerate wider adoption from testing to clinical practice. A crucial date in industry leaders’ calendar, this three-day meeting is your definitive platform designed to enable detection, diagnosis and monitoring of cancer, positioning LBx techniques and related therapeutics to achieve their clinical and commercial potential. Bringing together leading experts, practitioners and technical decision makers, this is your opportunity to hear how fluid based biodetection is improving for all circulating biomarkers, including CTCs, ctDNA, cfmiRNA and exosomes. Joined by the likes of the FDA, Pfizer, BMS, National Cancer Institute and MSKCC, you can gain insights from world-renowned experts on the significant progress being made to escalate the translation of liquid biopsies into clinical programs.
- Share your Experience